OncoCyte Corp. (OCX) Has Jumped To A 5-Month High On Study Results

OncoCyte Corp. (OCX) reported positive results from its most recent study of DetermaVu, its lung cancer diagnostic blood test, Tuesday morning.

OncoCyte has gapped open sharply higher this morning and is now up 0.95 at $4.00 on strong volume. The stock has broken out to a 5-month high.

by RTTNews Staff Writer

Source: Read Full Article